| BCOSX | VTBSX | BCOSX / VTBSX | |
| Total Expense Ratio | 0.55 | 0.01 | 5,500% |
| Annual Report Gross Expense Ratio | 0.55 | 0.01 | 5,500% |
| Fund Existence | 25 years | 10 years | - |
| Gain YTD | 0.090 | -0.307 | -29% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 3000000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 44.5B | 385B | 12% |
| Annual Yield % from dividends | 3.76 | 3.92 | 96% |
| Returns for 1 year | 6.09 | 2.31 | 263% |
| Returns for 3 years | 12.79 | -0.10 | -12,473% |
| Returns for 5 years | 0.33 | -14.81 | -2% |
| Returns for 10 years | 25.73 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LABD | 18.91 | 1.01 | +5.64% |
| Direxion Daily S&P Biotech Bear 3X ETF | |||
| RWJ | 53.68 | 0.91 | +1.72% |
| Invesco S&P SmallCap 600 Revenue ETF | |||
| PSP | 64.34 | 0.13 | +0.20% |
| Invesco Global Listed Private Equity ETF | |||
| HIMY | 5.43 | N/A | N/A |
| Defiance Leveraged Long +Income HIMS ETF | |||
| BKCG | 36.31 | -0.09 | -0.25% |
| BNY Mellon Concentrated Growth ETF | |||